Association of breast cancer and its therapy with menopause-related symptoms.
about
Vulvovaginal atrophy.Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivorsTheories, models, and frameworks related to sleep-wake disturbances in the context of cancerSoy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis.Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?Sexual problems, communication patterns, and depressive symptoms in couples coping with metastatic breast cancer.Perceived control and hot flashes in treatment-seeking breast cancer survivors and menopausal women.Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Contemporary quality of life issues affecting gynecologic cancer survivors.Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivorsOvercoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophyClinical Pearls in breast diseaseComparison of the Hyaluronic Acid Vaginal Cream and Conjugated Estrogen Used in Treatment of Vaginal Atrophy of Menopause Women: A Randomized Controlled Clinical TrialPerceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.Premature menopause in young breast cancer: effects on quality of life and treatment interventions.Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.Qualitative assessment of information and decision support needs for managing menopausal symptoms after breast cancer.Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study.Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review.Cancer-related fatigue: implications for breast cancer survivors.Animal models for the effective development of atrophic vaginitis therapies: possibilities and limitations.How long do the effects of acupuncture on hot flashes persist in cancer patients?Management of menopause in women with breast cancer.Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy.Urban voices: the quality-of-life experience among women of color with breast cancer.Younger and older women's concerns about menopause after breast cancer.Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.Characteristics of breast cancer patients who experience menopausal transition due to treatment.Influence of Menopausal Status on the Symptom Experience of Women Before Breast Cancer Surgery.Challenges of measuring accurate estradiol levels in aromatase inhibitor-treated postmenopausal breast cancer patients on vaginal estrogen therapy.Menopausal-related Symptoms in Women One Year After Breast Cancer Surgery.Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial.Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis.Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.
P2860
Q33566744-BB798688-F6C4-477A-B353-BB6BB6E9762AQ33628455-F98677DB-CC7C-473A-9500-D07C817E7CEAQ33746510-04FA2857-9145-44FE-B7AB-13EB7377B35AQ34015729-A6CB5B88-3BCE-4D8C-B47F-936F9632ACB7Q34970602-8DF488F0-B1A0-449B-A12F-4DDC8D6DE053Q35084910-35431D7B-B5EB-46AD-9CDD-8C0287928712Q35596993-07225775-16F6-481C-B283-747E6A18CCABQ35643128-7EC99999-9BE5-4E32-B12A-BCD3FC537D72Q35824414-D5BFA966-3A49-4589-96C0-DAF4E139C04BQ36067725-ED0AE7BA-8DE0-4691-8BA2-165C397D37A6Q36204133-1C3C0A72-2098-4877-BF70-AF055AF30E3EQ36326412-465B4916-B139-433F-869A-AE92405B18F3Q36399021-711438DE-02FE-4375-896E-B7FA7F773946Q36454065-F0B87EB9-3D1D-419E-85E9-193F4FBFF917Q36654489-B464DBB7-E4D9-4A5C-8A61-0E2D36063B29Q36963345-CCC5D16B-3602-4E7F-B633-4B35FC12644EQ37103134-D80CAD04-598A-4A7A-948D-09A7354B13F9Q37163473-CB5DCEA3-77CD-4518-977A-C6026BA59F48Q37273440-6E276A3A-C548-42DE-A97B-9DF119034893Q37442229-F14B5D59-9DA6-474C-BE7B-41895F6B5EFCQ37594895-3410A146-E137-4A72-889D-074ACD7BE870Q37978292-A78DD17B-AA48-4ACA-844B-5FE6C4DA13CDQ38001375-E62602A2-E0AA-4C14-83AC-04B34070EC9DQ38176446-95D83740-8926-4738-9B56-2D6F8980014EQ38183256-EC260C48-A9AB-42AA-9FD8-9594E759FB9CQ38298951-089E1255-50AA-4973-9E8B-2ADD1909D67EQ38792918-77496675-1173-4433-ADC5-CF6FD582D3DCQ38834129-E5204C62-FF38-48DC-84D6-25268D12BE39Q39801484-0C896C08-46C0-4E51-B3D8-79C79EA7A3BAQ44028918-1888430E-302B-4989-B53A-87884EF4521AQ45958149-DB73DD16-32A6-4757-A07E-2E078E87893DQ46332241-94B67CDE-B4A3-44C1-AE45-8A8221274555Q46965840-1486B04E-F9F7-4275-8D3D-733F3C700463Q47139346-74B606AA-AD8B-4BD6-AB4A-CDFE2B16D139Q47683668-2DE161CC-1528-4C54-8772-C1E80FA1B7F9Q48058845-A2A65C91-832F-4658-B739-E4BE90D75484Q48505898-D20AD179-5AD3-4D3C-872B-A2E4703758CDQ51382005-864FC9C4-BC64-43A9-BE99-A4673B4AA065Q51809566-E620763B-55DD-4C57-9777-1702E69DA4A3Q52720179-C1BA271F-0031-4321-94E1-CB14188C53BB
P2860
Association of breast cancer and its therapy with menopause-related symptoms.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Association of breast cancer and its therapy with menopause-related symptoms.
@en
Association of breast cancer and its therapy with menopause-related symptoms.
@nl
type
label
Association of breast cancer and its therapy with menopause-related symptoms.
@en
Association of breast cancer and its therapy with menopause-related symptoms.
@nl
prefLabel
Association of breast cancer and its therapy with menopause-related symptoms.
@en
Association of breast cancer and its therapy with menopause-related symptoms.
@nl
P2093
P1433
P1476
Association of breast cancer and its therapy with menopause-related symptoms.
@en
P2093
Carolyn Crandall
Gail A Greendale
Laura Petersen
Patricia A Ganz
P304
P356
10.1097/01.GME.0000117061.40493.AB
P407
P577
2004-09-01T00:00:00Z